AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitadiet-Met 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Johnlee Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitadiet-Met 50/1000 Tablet

Combinazione-DM 50/1000 tablets effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication helps mitigate severe diabetic complications, including renal impairment and vision loss, and potentially lowers the risk of cardiovascular events. Combinazione-DM 50/1000 may be used as a standalone therapy or in conjunction with other antidiabetic agents. Optimal results are achieved through concurrent adherence to a balanced diet and regular physical activity. Dosage is personalized, considering your health status, glycemic control, and other medications. Consuming the tablets with meals minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes efficacy; discontinuation should only occur under medical guidance. Maintaining the prescribed diet and exercise plan is crucial for diabetes management, as lifestyle significantly impacts glycemic control. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; learn to recognize and manage this condition. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals must consult their doctor. Interactions with other medications are possible; disclose all medications to ensure safety. Alcohol should be limited due to its potential to exacerbate hypoglycemia. Your physician will monitor renal function and blood glucose levels throughout treatment.

Uses of Sitadiet-Met 50/1000 Tablet

Managing type 2 diabetes

Major Benefits of Sitadiet-Met 50/1000 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sitadiet-Met 50/1000 Tablets. Ingest the tablets whole; do not break, crush, or chew them. Administer this medication with food.

Common Side effects of Sitadiet-Met 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitadiet-Met 50/1000 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Sitadiet-Met 50/1000 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Sitadiet-Met 50/1000 Tablet works:

Sitadiet-Met 50/1000 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitadiet-Met 50/1000 Tablets is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Sitadiet-Met 50/1000 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitadiet-Met 50/1000 tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitadiet-Met 50/1000 Tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. This medication is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver impairment should likely refrain from using Sitadiet-Met 50/1000 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitadiet-Met 50/1000 Tablet :

Should you forget a Sitadiet-Met 50/1000 Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitadiet-Met 50/1000 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitadiet-Met 50/1000 Tablet

Sitadiet-Met 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitadiet-Met 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitadiet-Met 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Sitadiet-Met 50/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitadiet-Met 50/1000 tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Sitadiet-Met 50/1000) can rarely cause lactic acidosis (MALA, Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This risk is higher in individuals with kidney disease, older adults, and heavy alcohol users, hence metformin is avoided in such cases. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. Seek immediate medical attention and discontinue Sitagliptin/Metformin if these symptoms appear.
Sitadiet-Met 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitadiet-Met 50/1000 Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Sitadiet-Met 50/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also be avoided by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitadiet-Met 50/1000 tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (Sitadiet-Met 50/1000 Tablet) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitadiet-Met 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitadiet-Met 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitadiet-Met 50/1000 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Sitadiet-Met 50/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitadiet-Met 50/1000 tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (Sitadiet-Met 50/1000) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitadiet-Met 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication safely and ensure it's inaccessible to children, pets, and others.
Sitadiet-Met 50/1000 Tabl...
359
MRP 416
13% off